Vanguard Fiduciary Trust
IMRX icon

Vanguard Fiduciary Trust’s Immuneering IMRX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
360,764
+38,726
+12% +$196K ﹤0.01% 2728
2026
Q1 		$1.7M Buy
+322,038
New +$1.65M ﹤0.01% 2650

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Vanguard Fiduciary Trust's IMRX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Immuneering (IMRX) stake by 12% in Q2 2026, buying an estimated $196K and bringing the position to 360,764 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Vanguard Fiduciary Trust first reported a position in IMRX in Q1 2026 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Vanguard Fiduciary Trust held 360,764 shares of Immuneering worth $1.8M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 38,726 Immuneering shares in Q2 2026, an estimated $196K.
  • Immuneering made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2728 holding.
  • Vanguard Fiduciary Trust first reported a position in Immuneering in Q1 2026 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.